Drug Res (Stuttg) 2019; 69(11): 612-620
DOI: 10.1055/a-0958-1987
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Effects of Nitroglycerine on Renal Ischemia-Reperfusion Injury in Adult Male Rats

Fatemeh Ahmadi
1   Arak University of Medical Sciences, Arak, Iran
,
Saeed Hajihashemi
2   Department of Physiology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran
,
Ali Rahbari
3   Department of Pathology, Arak University of Medical Sciences, Arak, Iran
,
Fatemeh Ghanbari
4   Department of Pharmacology, Islamic Azad University, Arak Branch, Arak, Iran
› Author Affiliations
Further Information

Publication History

received 13 April 2019

accepted 11 June 2019

Publication Date:
17 July 2019 (online)

Abstract

Background Ischemia-reperfusion (I-R) leads to acute kidney injury (AKI). The present study investigated the effects of nitroglycerine (NG) on improving renal dysfunctions caused by I-R in rats.

Methodology Twenty-four rats were equally divided into four groups: (1) the control group, (2) the sham group, (3) the I-R group, and (4) NG-treated groups.NG (50 μg/kg) was injected intraperitoneally after induction of IR. I-R was induced through clamping of the bilateral renal artery and vein of both kidneys for 20 min followed by 24 h of reperfusion.

Results NG significantly increased the creatinine clearance levels and renal blood flow rate (which was reduced by I-R). NG also significantly improved serum electrolytes (sodium and potassium) that were disordered by I-R. In addition, NG significantly offset impaired antioxidant defense mechanism and inhibited lipid peroxidation.

Conclusions The results show NG has a protective effect on renal tissue against AKI caused by I-R. These protective effects mediated through antioxidant activity and decrease of lipid peroxidation.

 
  • References

  • 1 Makris K, Spanou L. Acute kidney injury: Definition, pathophysiology and clinical phenotypes. The Clinical Biochemist Reviews 2016; 37-85
  • 2 Palevsky PM. Definition and staging criteria of acute kidney injury in adults. 2018 uptodate.com
  • 3 Patschan D, Müller GA. Acute kidney injury. Journal of Injury and Violence Research 2015; 7-19
  • 4 Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. The Journal of Clinical Investigation 2011; 121: 4210-4221
  • 5 Sancho-Martínez SM, López-Novoa JM, López-Hernández FJ. Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury. Clinical Kidney Journal 2015; 8: 548-559
  • 6 Le Clef N, Verhulst A, D’Haese PC. et al. Unilateral renal ischemiareperfusion as a robust model for acute to chronic kidney injury in mice. PloS One 2016; 11: e0152153
  • 7 Tousoulis D, Kampoli AM, Tentolouris Nikolaos. et al. The role of nitric oxide on endothelial function. Current Vascular Pharmacology 2012; 10: 4-18
  • 8 Nath R, Dixit R, Pal R. et al. Nitric oxide (NO) a free radical and a messenger molecule.International. Journal of Current Research 2013; 5: 907-911
  • 9 Badavi M, Naseri MKG, Pirmoradi L. et al. Beta carotene modulates nitric oxide production in the renal ischemia/reperfusion injury in rat. Zahedan Journal of Research in Medical Sciences 2017; 19 (03) e7662
  • 10 Roberts BW, Mitchell J, Kilgannon JH. et al. Nitric oxide donor agents for the treatment of ischemia/reperfusion injury in human subjects: A Systematic Review. Shock 2013; 39: 229-239
  • 11 Phillips L, Toledo AH, Lopez-Neblina F. et al. Nitric oxide mechanism of protection in ischemia and reperfusion injury. Journal of Investigative Surgery 2009; 22: 46-55
  • 12 Förstermann U, Sessa WC. Nitric oxide synthases: Regulation and function. European Heart Journal 2011; 33: 829-837
  • 13 Polakowska M, Orzelska-Gorka J, Talarek S. Drugs modulating the L-arginine: NO: cGMP pathway–current use in therapy. Current Issues in Pharmacy and Medical Sciences 2016; 29: 14-20
  • 14 Zahoor MU, Masroor R, Ali MW. Use of lignocaine or nitroglycerine for blunting of hemodynamic stress response during electroconvulsive therapy. Egyptian Journal of Anaesthesia 2014; 30: 27-30
  • 15 Hesketh EE, Czopek A, Clay M. et al. Renal ischaemia reperfusion injury: A mouse model of injury and regeneration. Journal of Visualized Experiments 2014; 88: e 51816
  • 16 Suleyman Z, Sener E, Kurt N. et al. The effect of nimesulide on oxidative damage inflicted by ischemia–reperfusion on the rat renal tissue. Renal failure 2015; 37: 323-331
  • 17 Zou L, Wang W, Liu S. et al. Spontaneous hypertension occurs with adipose tissue dysfunction in perilipin-1 null mice. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 2016; 1862: 182-191
  • 18 Hajihashemi S, Hamidizad Z, Rahbari A. et al. Effects of cobalamin (Vitamin B12) on gentamicin induced nephrotoxicity in rat. Drug research 2017; 67: 710-718
  • 19 Mukai K, Kuda Y, Shibamoto T. et al. Renal response to anaphylaxis in anesthetized rats and isolated perfused rat kidneys: Roles of nitric oxide. The Journal of Physiological Sciences 2018; 68 p 689-697
  • 20 Hajihashemi S, Jafarian T, Ahmadi M. et al. Ameliorative effects of zataria multiflora hydro-alcoholic extract on gentamicin induced nephrotoxic-ity in rats. Drug research 2018; 68: 387-394
  • 21 Cao Y, Gao X, Yang Y. et al. Changing expression profiles of longnon-coding RNAs, mRNAs and circular RNAs in ethylene glycolinduced kidney calculi rats. BMC genomics 2018; 19: 660
  • 22 Antony AS, Gomathy S, Rajmohan T. et al. Pharmacological evaluation of curcumin for its nephroprotective activity in 5/6 nephrectomized rat model. Drug Invention Today 2018; 10: 10-13
  • 23 Kristensen MLV, Kierulf-Lassen C, Nielsen PM. et al. Remote ischemic perconditioning attenuates ischemia/reperfusion-induced downregulation of AQP2 in rat kidney. Physiological reports 2016; 4: e12865
  • 24 Ahmadi M, Hajihashemi S, Rahbari A. et al. The effects of diclofenac on renal toxicity disorders induced by gentamicin in rats. Journal of Babol University of Medical Sciences 2018; 20: 33-41
  • 25 Chole RH, Patil RN, Basak A. et al. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. Journal of Cancer Research and Therapeutics 2010; 6: 487-491
  • 26 Ustundag Y, Huysal K, Kahvecioglu S. et al. Establishing reference values and evaluation of an in-house ferric reducing antioxidant power (FRAP) colorimetric assay in microplates. The European Research Journal 2016; 2: 126-131
  • 27 Ahmadi M, Hajihashemi S, Chehrei A. et al. Therapeutic effects of Urtica dioica methanolic extract on gentamicin induced nephrotoxicity in rats. Koomesh 2014; 15: 220-231
  • 28 Yu C, Qi D, Sun J-F. et al. Rhein prevents endotoxin-induced acute kidney injury by inhibiting NF-κB activities. Scientific reports 2015; 5: 11822
  • 29 Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Comprehensive Physiology 2011; 2: 1303-1353
  • 30 Chatauret N, Badet L, Barrou B. et al. Ischemia-reperfusion: From cell biology to acute kidney injury. Progrès en urologie 2014; 24: S4-S12
  • 31 Miller WL, Cavero PG, Aarhus LL. et al. Endothelin-mediated cardiorenal hemodynamic and neuroendocrine effects are attenuated by nitroglycerin in vivo. American Journal of Hypertension 1993; 6: 156-163
  • 32 Krishnan S, Kraehling J, Eitner F. et al. The Impact of the nitric oxide (NO)/soluble guanylyl cyclase (sGC) signaling cascade on kidney health and disease: A preclinical perspective. International Journal of Molecular Sciences 2018; 19: 1712
  • 33 Vallon V. Tubular transport in acute kidney injury: Relevance for diagnosis, prognosis and intervention. Nephron 2016; 134: 160-166
  • 34 Palmer BF. Potassium homeostasis in chronic kidney disease. Nephrology News & Issues 2016; 30 suppl 8-10 12-13
  • 35 Mount P, Power DA. Nitric oxide in the kidney: Functions and regulation of synthesis. Acta Physiologica 2006; 187: 433-446
  • 36 Chow SL, O’barr SA, Peng J. et al. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure. Journal of Cardiac Failure 2011; 17: 181-187
  • 37 Sharma S. Nitric oxide and the kidney. Indian J Nephrol 2004; 14: 77-84
  • 38 Lee J. Nitric oxide in the kidney: its physiological role and pathophysi ological implications. Electrolyte & Blood Pressure 2008; 6: 27-34
  • 39 Sabbahy ME, Vaidya VS. Ischemic kidney injury and mechanisms of tissue repair. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2011; 3: 606-618
  • 40 Hutchens MP, Dunlap J, Hurn PD. et al. Renal ischemia: does sex matter?. Anesthesia & Analgesia 2008; 107: 239-249
  • 41 Sen S, Doger FK, Sen S. et al. The protective effect of nitroglycerin on gastrointestinal and renal side effects of lornoxicam in rats. European Journal of Pharmacology 2006; 541: 191-197
  • 42 Basile P. D Yoder MC. Renal endothelial dysfunction in acute kidney ischemia reperfusion injury. Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets- Cardiovascular & Hematological Disorders) 2014; 14: 3-14
  • 43 Mercatello A. Changes in renal function induced by anesthesia. In Annales francaises d'anesthesie et de reanimation. 1990; 9: 507-524
  • 44 Kucuk HF, Kaptanoglu L, Ozalp F. et al. Role of glyceryl trinitrate, a nitric oxide donor, in the renal ischemia-reperfusion injury of rats. European surgical research 2006; 38: 431-437